Some have relabeled it as Pentadecapeptide Aringate or PDA (switching the acetate to an arginate) and are prescribing it for subcutaneous administration this way, whilst the confusion about its position has led to a vivid oral capsule market for BPC in what appears to generally be a grey spot of https://chicka542ira7.azzablog.com/profile